Hypothesis

In aging neurons, reduced calcineurin‑NFATc4 signaling lowers nuclear retention of NFATc4, which diminishes NFATc4‑driven transcription of the microRNA miR‑23a and of protective secretory proteins. The loss of miR‑23a lifts repression of atrophy‑related genes (e.g., neuronal analogues of MuRF1/atrogin‑1) and decreases expression of neuronal “don’t‑eat‑me” signals such as CD47 or fractalkine (CX3CL1). Consequently, neurons display increased surface phosphatidylserine and complement C3 deposition, marking them for phagocytosis by microglia. This mechanism provides a direct link between neuronal activity patterns, metabolic efficiency, and active cell eviction, mirroring the CaN‑NFAT‑miR‑23a atrophy‑prevention axis observed in skeletal muscle.

Mechanistic Reasoning

1. NFATc4 as a calcium‑activity sensor – Hippocampal neurons show uniquely prolonged NFATc4 nuclear residency after calcium transients [2], suggesting it integrates sustained, low‑frequency activity that correlates with metabolic demand.
2. Transcriptional output – NFATc4 binds promoters of Mir23a and genes encoding secreted immunomodulatory proteins (e.g., Cx3cl1, Cd47). Reduced nuclear NFATc4 lowers these transcripts.
3. miR‑23a downstream effect – miR‑23a suppresses translation of atrophy‑linked mRNAs in muscle [4]; analogous neuronal targets include genes involved in cytoskeletal dynamics and synaptic vesicle cycling. Derepression leads to structural weakening and increased “eat‑me” ligand exposure.
4. Microglial recognition – Loss of CD47/fractalkine and gain of phosphatidylserine/C3b tip the balance toward microglial phagocytosis, a process well‑characterized in developmental synaptic pruning and increasingly implicated in age‑related neuronal loss.

Testable Predictions

• Prediction 1: In aged mice, hippocampal neurons exhibit decreased NFATc4 nuclear localization, reduced miR‑23a levels, and elevated C3 deposition compared with young adults.
• Prediction 2: Neuron‑specific overexpression of a constitutively active NFATc4 (NFATc4‑CA) in aged mice will rescue miR‑23a expression, attenuate complement tagging, and preserve neuronal numbers without altering baseline activity.
• Prediction 3: Conditional knockout of Nfatc4 in forebrain excitatory neurons will accelerate age‑dependent neuronal loss and microglial phagocytosis, which can be blocked by pharmacological inhibition of complement C3aR.
• Prediction 4: Restoring miR‑23a via viral delivery in Nfatc4‑deficient neurons will compensate for the loss of NFATc4, reducing atrophy‑gene expression and microglial engulfment despite low NFATc4 activity.

Experimental Approach

1. Use immunohistochemistry and subcellular fractionation to quantify NFATc4 nuclear/cytoplasmic ratios in hippocampal CA1 layers of 3‑ vs 24‑month‑old mice.
2. Perform small‑RNA sequencing on laser‑captured neurons to assess miR‑23a and atrophy‑gene transcripts.
3. Deploy AAV‑Syn‑NFATc4‑CA or AAV‑Syn‑Cre in Nfatc4^fl/fl^ mice to manipulate NFATc4 activity specifically in neurons.
4. Measure microglial phagocytic activity via in vivo two‑photon imaging of labeled synapses and flow cytometry for neuronal debris in microglial lysates.
5. Apply complement inhibition (C3aR antagonist) or miR‑23a mimics to test rescue of neuronal survival.

Falsifiability

If neuronal NFATc4 nuclear retention, miR‑23a levels, or complement tagging do not correlate with age‑dependent neuronal loss, or if manipulating NFATc4/miR‑23a fails to alter microglial phagocytosis or neuron numbers, the hypothesis would be refuted. Conversely, consistent support across these assays would substantiate the proposal that the CaN‑NFATc4‑miR‑23a axis functions as an activity‑dependent quality‑control checkpoint that eliminates inefficient neurons during brain aging.